[Directives for digitalis therapy in childhood].
D000293:Adolescent; D000367:Age Factors; D001830:Body Surface Area; D002648:Child; D002675:Child, Preschool; D004071:Digitalis Glycosides / Q000627:therapeutic use*; D004074:Digitoxin / Q000627:therapeutic use; D004077:Digoxin / Q000627:therapeutic use; D004361:Drug Tolerance; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007799:Lanatosides / Q000627:therapeutic use; D008297:Male; D013328:Strophanthins / Q000627:therapeutic use
D004071:Digitalis Glycosides; D007799:Lanatosides; D013328:Strophanthins; D004077:Digoxin; D004074:Digitoxin
Richtlinien für die Digitalis-Therapie im Kindesalter.